| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |